Brought to you by:
From reactive to proactive: CHAMPIONS builds nationwide effort around PAD prevention
“We’ve always approached peripheral artery disease in a very reactive way in that we wait for a patient to show up in our office or the emergency room with claudication, rest pain or gangrene and only then do we intervene,…
SEISMIQ IVL offers targeted approach to increasingly complex PAD
This video is sponsored by Boston Scientific. Nicolas Mouawad, MD, chief of vascular surgery at McLaren Health in Bay City, Michigan, discussed the growing challenge of treating peripheral artery disease (PAD) as an aging patient population presents with increasingly complex,…
Study links clopidogrel genetic variants to cardiovascular risk after PAD intervention
Genetic variants that reduce the effectiveness of clopidogrel may increase the risk of heart attack and stroke in patients undergoing peripheral artery disease (PAD) interventions, according to research presented at VAM 2026. The study found that around one in five…
‘Treat the water, not just the pipes’: Addressing prevention in vascular care
“The artery is ours and it should be all of it,” said Lily Johnston, MD. “Trying to reroute the blood flow without changing what runs through it is like changing the pipes in a house without addressing the toxic wastewater…
Elective PVI for claudication linked to worse limb outcomes and higher costs
Vascular surgeons have long debated whether and when to intervene on claudication. A new study suggests the field may be intervening too often, too early and with consequences that compound over time. The findings, recently published in the Journal of…
Rethinking antiplatelet and anticoagulant use in PAD after AQUATIC
During Thursday’s Hot Topics session, John Curci, MD, an associate professor at Vanderbilt Health, discussed the changing landscape of long-term antiplatelet and anticoagulant use in the management of peripheral artery disease (PAD) in light of results from the AQUATIC trial.…
Advances in medical management could redefine PAD care
“Peripheral arterial disease [PAD] should no longer be viewed simply as a problem of arterial obstruction requiring procedural intervention,” said Mohamed Zayed, MD, PhD, associate professor of Surgery and Radiology at Washington University School of Medicine. That assertion cuts to…
Study reveals higher PAD detection rates in women despite similar risk profiles
Women may be more likely than men to have undiagnosed peripheral artery disease (PAD) at the time of screening, despite meeting similar risk criteria, according to new data from a community-based screening program targeting underserved populations. The study analyzed participants…
Advancing below-the-knee intervention in CLTI with Shockwave Javelin Peripheral IVL
This advertorial is sponsored by Shockwave Medical. Charles Bailey, MD, George Adams, MD and Vanessa Adams, BS, share their experience with Shockwave Javelin, the first-of-its-kind forward intravascular lithotripsy (IVL) technology that is enabling further interventional treatment for patients suffering from…
Smoking cessation remains a challenge among PAD patients undergoing revascularization
Smoking cessation rates among patients with peripheral artery disease (PAD) undergoing lower extremity revascularization (LER) remain low and largely unchanged, according to a new analysis of Vascular Quality Initiative (VQI) data. The retrospective study, which was published in the Journal…